3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Obesity
1
Metabolic Syndrome
1
Hyperthermia
1
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Topiramate
1
Tirzepatide
1
Testosterone
1
Qsymia
1
Phentermine
1
Pancreaticoduodenectomy
1
Naltrexone
1
Medical History Taking
1
Magnetic Resonance Spectroscopy
1
Liraglutide
1
Hepatectomy
1
Hematologic Tests
1
Gonadotropin-Releasing Hormone
1
Glucagon-Like Peptide-1 Receptor
1
Diethylpropion
1
Diathermy
1
Colonoscopy
1
Bupropion
1
Blood Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Diathermy
×
Other
×
Clear all
NCT03644524
2018-08-23
CMH
University of Oregon
Phase NA
Completed
20 enrolled